Alpha 1 antichymotrypsin Monoklonaler Antikörper

Alpha 1 antichymotrypsin Monoklonal Antikörper für WB, IHC, IF-P, Indirect ELISA

Wirt / Isotyp

Maus / IgG2b

Getestete Reaktivität

Hausschwein, human

Anwendung

WB, IHC, IF-P, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

3F2F10

Kat-Nr. : 66078-1-PBS

Synonyme

Alpha Antichymotrypsin, SERPINA3, ACT, AACT, A-1-Antichymotrypsin



Geprüfte Anwendungen

Produktinformation

66078-1-PBS bindet in WB, IHC, IF-P, Indirect ELISA Alpha 1 antichymotrypsin und zeigt Reaktivität mit Hausschwein, human

Getestete Reaktivität Hausschwein, human
Wirt / Isotyp Maus / IgG2b
Klonalität Monoklonal
Typ Antikörper
Immunogen Alpha 1 antichymotrypsin fusion protein Ag2830
Vollständiger Name serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
Berechnetes Molekulargewicht 448 aa, 48 kDa
Beobachtetes Molekulargewicht 60 kDa
GenBank-ZugangsnummerBC010530
Gene symbol Alpha 1 Antichymotrypsin
Gene ID (NCBI) 12
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Human SerpinA3, also known as Alpha 1-antichymotrypsin (AACT), is a member of the serine protease inhibitor class, and is a plasma alpha globulin glycoprotein which increases in the blood during the inflammatory process. SerpinA3, is also an inhibitor of neutrophil cathepsin G, mast cell chymases and pancreatic chymotrypsin. SerpinA3 is produced primarily in the liver, and is identified as an acute-phase inflammatory protein. SerpinA3 deficiency has been associated with liver disease. SerpinA3 has also been implicated in the pathology of a number of devastating human diseases including chronic obstructive pulmonary disease (COPD), Parkinson's disease (PD), Alzheimer's disease (AD), Stroke, Cystic Fibrosis, Cerebral Haemorrhage and Multiple System Atrophy.